TITLE

Specific Characteristics of Patients with Advanced Genitourinary Cancer Receiving Specialized Inpatient Palliative Care

AUTHOR(S)
Iversen, Katharina; Oechsle, Karin; Oing, Christoph; Bokemeyer, Carsten; Seidel, Christoph
PUB. DATE
October 2017
SOURCE
Oncology Research & Treatment;Oct2017, Vol. 40 Issue 10, p609
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
Background: The aim of this study was to compare the characteristics for genitourinary cancer (GUC) patients receiving specialized inpatient palliative care (SIPC) with those of a general cohort. Methods: We retrospectively evaluated 151 GUC patients receiving SIPC from 2008 to 2014 regarding symptoms, problems, treatment, and outcome. These characteristics were compared with a general cohort of 1,285 patients with various diseases who received SIPC (German Hospice and Palliative care investigation: HOPE). Results: Patients suffering from advanced prostate cancer (n = 59), renal cell cancer (n = 37), urothelial cancer (n = 36), urothelial accompanied by prostate cancer (n = 11), germ cell cancer (n = 7), and penile squamous cell cancer (n = 1) were included in the study. Most frequent symptoms and problems at admission were weakness (93%), the need for assistance with activities of daily living (85%), loss of appetite (81%), and organization of care (80%). Symptoms were more frequent in the GUC than in the general cohort during treatment, in particular with regards to pain (p < 0.001), tension (p < 0.001), nausea (p = 0.001), and vomiting (p < 0.001). GUC patients received significantly more opioids with 89% compared to the general cohort with 72% (p < 0.001). Conclusion: Symptom burden of GUC patients, in particular pain, tension, and nausea was higher compared to the general cohort, and analgesic treatment played an important role in achieving control of symptoms.
ACCESSION #
125528763

 

Related Articles

  • “Now that You Mention it, Doctor ... ”: Symptom Reporting and the Need for Systematic Questioning in a Specialist Palliative Care Unit. White, Clare; McMullan, Damien; Doyle, Julie // Journal of Palliative Medicine;May2009, Vol. 12 Issue 5, p447 

    Aims: To determine which symptoms experienced by patients admitted to a specialist palliative care unit are self-reported (SR) and which are only detected with systematic questioning (SQ). Methods: A retrospective chart review was performed of 50 patients. The admission proforma was reviewed to...

  • Rapid palliation of symptoms with platinumbased chemotherapy plus cetuximab in recurrent oral cancer: a case report. Mes�a, Ricard; Palmero, Ram�n; Cos, M�nica; Vilajosana, Esther; V�zquez, Silvia // Head & Neck Oncology;2010, Vol. 2 Issue 1, p1 

    Background: Symptom control is an important consideration in the choice of treatment for patients with recurrent and/or metastatic squamous cell carcinoma of the head and neck (SCCHN). Patients who demonstrate objective tumour responses to platinum-based chemotherapy are more likely to have...

  • Current measures of metabolic heterogeneity within cervical cancer do not predict disease outcome. Brooks, Frank J.; Grigsby, Perry W. // Radiation Oncology;2011, Vol. 6 Issue 1, p69 

    Purpose: To access the long-time outcome and patterns of failure in patients with advanced head and neck squamous cell carcinoma (HNSCC). Methods and materials: Between 1992 and 2005 127 patients (median age 55 years, UICC stage III n = 6, stage IV n = 121) with primarily inoperable, advanced...

  • Long-term outcome and patterns of failure in patients with advanced head and neck cancer. Hauswald, Henrik; Simon, Christian; Hecht, Simone; Debus, Juergen; Lindel, Katja // Radiation Oncology;2011, Vol. 6 Issue 1, p70 

    Purpose: To access the long-time outcome and patterns of failure in patients with advanced head and neck squamous cell carcinoma (HNSCC). Methods and materials: Between 1992 and 2005 127 patients (median age 55 years, UICC stage III n = 6, stage IV n = 121) with primarily inoperable, advanced...

  • Gemcitabine as a Radiosensitizer for Nonresectable Feline Oral Squamous Cell Carcinoma. Jones, Pamela D.; De Lorimier, Louis-Philippe; Kitchell, Barbara E.; Losonsky, John M. // Journal of the American Animal Hospital Association;Sep/Oct2003, Vol. 39 Issue 5, p463 

    Presents a study which evaluated the efficacy of low-dose gemcitabine used with palliative radiotherapy for the treatment of inoperable oral squamous cell carcinoma (SCC) in cats. Methodology of the study; Effects of Gemcitabine on cats; Results and discussion.

  • Squamous cell carcinoma of the scrotum in a Nigerian:case report. Azike, Jerome E.; Chukwujama, N. O.; Oguike, T. C. // Rare Tumors;2009, Vol. 1, p4 

    Squamous cell carcinoma of the scrotum is rare and to the best of our knowledge has never been reported from Nigeria. We report on a case thought to be occupation-related in a 42-year old Nigerian taxi driver who had previously been an automobile mechanic and later a long-haul truck driver. He...

  • Treatments and costs for recurrent and/or metastatic squamous cell carcinoma of the head and neck in the Netherlands. Linden, Naomi; Buter, Jan; Pescott, Chris; Lalisang, Roy; Boer, Jan; Graeff, Alexander; Herpen, Carla; Baatenburg de Jong, Robert; Uyl-de Groot, Carin // European Archives of Oto-Rhino-Laryngology;Feb2016, Vol. 273 Issue 2, p455 

    For patients with recurrent and/or metastatic squamous cell carcinoma of the head and neck (R/M SCCHN), chemotherapy can prolong life and alleviate symptoms. However, expected gains may be small, not necessarily outweighing considerable toxicity and high costs. Treatment choice is to a large...

  • Hypercalcemia of Malignancy #151. Siddiqui, Fareeha; Weissman, David E. // Journal of Palliative Medicine;Jan2010, Vol. 13 Issue 1, p77 

    The article provides information on hypercalcemia. It mentions that squamous cell cancers are most common which will lead to hypercelcemia. It notes the symptoms or signs of this disease, which includes sedation, anorexia and dehydration. It states that vigorous hydration and bisphosphonates are...

  • Palliative Radiotherapy in Esophageal Cancer. Prasad, N.; Karthigeyan, M.; Vikram, Kate; Parthasarathy, R.; Reddy, K. // Indian Journal of Surgery;Feb2015, Vol. 77 Issue 1, p34 

    The present study was undertaken to evaluate the efficacy of radiotherapy in palliation of dysphagia in patients with squamous cell carcinoma (SCC) of esophagus and to see the quality of life (QoL) following radiotherapy. This was a prospective clinical study done between September 2006 and May...

  • What can mislead you to suspect appendicitis?  // RN;Jul76, Vol. 39 Issue 7, pOR4 

    Reports on the indicators of appendicitis. Percentage of patients with abdominal tenderness recorded at Saint Finbarr's Hospital and University College in Cork, Ireland; Facts on anorexia among the patients; Vomiting.

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics